Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes.
about
Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutionsAdenosine receptors: therapeutic aspects for inflammatory and immune diseases.A2A receptors in inflammation and injury: lessons learned from transgenic animalsInflammation and Inflammatory Cells in Myocardial Infarction and Reperfusion Injury: A Double-Edged SwordCommunication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injuryBeneficial and detrimental role of adenosine signaling in diseases and therapyTumor necrosis factor-α and lymphotoxin-α mediate myocardial ischemic injury via TNF receptor 1, but are cardioprotective when activating TNF receptor 2The spleen contributes importantly to myocardial infarct exacerbation during post-ischemic reperfusion in mice via signaling between cardiac HMGB1 and splenic RAGE.Adenosine 2B Receptor Activation Reduces Myocardial Reperfusion Injury by Promoting Anti-Inflammatory Macrophages Differentiation via PI3K/Akt Pathway.Splenic leukocytes mediate the hyperglycemic exacerbation of myocardial infarct size in mice.The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.Role of T-cells in myocardial infarction.DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Acute hyperglycemia abolishes ischemic preconditioning by inhibiting Akt phosphorylation: normalizing blood glucose before ischemia restores ischemic preconditioning.Targeting of adenosine receptors in ischemia-reperfusion injury.Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease.Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans developmentAdenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury.CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury.Acute hyperglycemia enhances oxidative stress and exacerbates myocardial infarction by activating nicotinamide adenine dinucleotide phosphate oxidase during reperfusion.Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRIThe role of adenosine A2A receptor signaling in bronchiolitis obliterans.Adenosine A2A receptor activation reduces infarct size in the isolated, perfused mouse heart by inhibiting resident cardiac mast cell degranulation.Inflammatory lung injury after cardiopulmonary bypass is attenuated by adenosine A(2A) receptor activation.Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction.Search for adenosine A2A spare receptors on peripheral human lymphocytesCardiac purinergic signalling in health and diseaseSOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expressionMammalian fetal cardiac regeneration after myocardial infarction is associated with differential gene expression compared with the adultAdenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Adenosine receptor-mediated cardioprotection: are all 4 subtypes required or redundant?Adenosine signaling during acute and chronic disease statesRegenerative healing following foetal myocardial infarction.β-defensin 2 as an adjuvant promotes anti-melanoma immune responses and inhibits the growth of implanted murine melanoma in vivo.Autoimmunity in CD73/Ecto-5'-nucleotidase deficient mice induces renal injuryHigh-throughput 13-parameter immunophenotyping identifies shifts in the circulating T-cell compartment following reperfusion in patients with acute myocardial infarction.International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an updateThe IL-33/ST2 pathway: therapeutic target and novel biomarker.T-helper1/T-helper2 cytokine imbalance in the iris of patients with glaucoma
P2860
Q24644038-3F9E423D-460F-4AC4-BB95-F2BD58A6F6AFQ24651475-925E1EFF-6261-44D0-813A-D440D2B9808FQ24652486-55E3FE41-4E59-4639-8067-B97FB6E99464Q26747421-9798B283-55AE-42C4-B098-23815356BC9DQ26830128-4DA3A316-D11A-47FF-BA21-205FEC35F4EFQ28080872-552EF92E-0857-4859-8812-06ED3F244727Q28488447-310DFA6B-A6E0-4F8D-9D4A-B604EF96BD30Q30275901-C0F22C00-CB2A-4293-98CD-6B0F337AA274Q30279041-686AA325-00B0-4C79-9FB3-52CF034B8B06Q30279293-A208A1E7-837C-4E13-A133-7CB4FA867D40Q30300583-5726B0F6-EE76-4D03-87FC-DAF2521A3124Q30315902-E13175B1-CA59-4C60-A5F1-380B3DF4D5ECQ30352934-734E432C-5ED5-488B-875E-D7A33F25F915Q30409961-0C535AF8-5F77-4620-9E16-F29C8053B7B1Q30415665-BC1FFBD8-14A1-4B43-A60A-CDABF28760D3Q30429069-4DF2F07C-905D-40DB-9626-300F6A7D522BQ30429393-BABAB48C-F5C7-4C24-A999-E36EEA40A257Q30429478-889EB364-EA9D-4049-B3EB-9C5E490C0550Q30433358-6854A785-F216-4EB2-9817-DC88B292C29EQ30436951-BC15F866-1D5B-4158-84FB-BDAFBE9D53CDQ30436954-83263824-F23C-4094-9115-3E92490A8C9BQ30437694-FEF77EB4-3F77-4110-8083-B04070779272Q30437818-D197554B-EACC-47DD-84DA-D854D4F99AB7Q30438024-7A8489A7-A247-4018-A47C-FF4079031C5CQ30438077-F029FA88-7F47-4497-BB97-1F6268D842BAQ30440124-953F485E-CEE2-46D3-9C36-AEE49BC30E2EQ33163021-EDB5FAEF-21E9-44EB-9DA5-E8DADABB195AQ33165093-39EDBCEF-1BEF-4CC1-8292-AC7568E45F07Q33460419-2D17F8E2-0E1A-4AE7-A156-0CF1FF04301CQ33569977-016A0BFC-AE6F-4E70-B781-E56F5099BAAAQ33615249-F978160A-75FE-49B8-B97A-6B700D220447Q34025792-E0FA9CFA-D603-40E7-9C51-2782D667A9F4Q34035228-7BB3A0EB-3D91-4298-8CA8-5985289F973EQ34063401-8EC59AE1-AFA3-425E-8AE7-25DC5E314386Q34163480-874B0A67-2DFC-4004-9756-4AD5E18A3B1FQ34292449-471895DE-C3E6-4DE8-8A42-789115C6F6EDQ34450587-B9A93571-9136-45B0-8B4E-4474F6301F26Q34701303-A5B89FD0-69DE-4FA4-B64F-9FFF399C167CQ34776884-231A86A5-DB32-475D-98FA-6641AA82AF49Q35219534-EA12DB07-206B-43B9-978C-761830F554A4
P2860
Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@ast
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@en
type
label
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@ast
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@en
prefLabel
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@ast
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@en
P2093
P50
P1433
P1476
Myocardial infarct-sparing eff ...... action on CD4+ T lymphocytes.
@en
P2093
Joel Linden
Melissa A Marshall
Susan I Ramos
Yuan-Ji Day
P304
P356
10.1161/CIRCULATIONAHA.106.649244
P407
P577
2006-10-23T00:00:00Z